Passing the Alzheimer’s Test Involves One’s Cannabinoid System ~ New on the Bryan William Brickner Blog

Boon Cannabinoids

“There’s a political cannabinoid boon happening,” opened Bryan W. Brickner, publisher of The Cannabis Papers: A citizen’s guide to cannabinoids (2011), “and this month the evidence is in our blood.”

In Passing the Alzheimer’s Test Involves One’s Cannabinoid System, new on the Bryan William Brickner Blog, numerous 2014 National Institutes of Health (PubMed) research updates regarding Alzheimer’s disease are highlighted. Notably, reported on CNN as Blood test predicts Alzheimer’s disease, there is a new test that predicts Alzheimer’s disease with 90% accuracy.

“This is a game changer,” Brickner commented, “so much so that Forbes magazine saw the ability to identify memory impairment before its onset as double-edged: they noted how the new Alzheimer’s test could kill long-term care insurance – or make it less expensive.”

“Yet, other than the blood test, this isn’t that new,” clarified Brickner: “CNN International reported six years ago on how cannabis may be a boon to Alzheimer’s patients.”

“While we wait for the boon (and it has to be a political boon now),” offered Brickner, “the progression of the disease doesn’t wait. We’d be wise to mimic the strength of Alzheimer’s disease in our resolve to understand its causes and to offer relief: the disease is relentless … we aught to be as well.”

Brickner has a 1997 political science doctorate from Purdue University and is the author of several books, to include The Promise Keepers (1999), Article the first of the Bill of Rights (2006), and The Book of the Is (2013). The Bryan William Brickner Blog is a collection of published works and press coverage and an ongoing resource for the political science of constitutions and the biological science of cannabinoids.